Literature DB >> 25881918

Oxidized HDL and LDL in adolescents with type 2 diabetes compared to normal weight and obese peers.

Monica T Marin1, Paul S Dasari1, Jeanie B Tryggestad1, Christopher E Aston2, April M Teague1, Kevin R Short3.   

Abstract

OBJECTIVE: Obesity and type 2 diabetes mellitus (T2DM) are associated with oxidative stress. Oxidative damage of high-density lipoprotein (oxHDL) leads to a dysfunctional molecule, potentially a mediator and/or marker of cardiometabolic disease. We tested the hypothesis that circulating concentration of oxHDL is higher in obese (Ob) or T2DM adolescents compared to normal-weight (NW) peers.
METHODS: In 37 NW, 38 Ob, and 42 T2DM adolescents, ages 11-18 y, fasting concentrations of HDL and LDL cholesterol, oxHDL, oxidized low-density lipoprotein (oxLDL), and myeloperoxidase (MPO) were measured.
RESULTS: Compared to the NW group, oxHDL in the Ob group was not different, but was 65% higher (p < 0.01) in the T2DM group. Within the T2DM group oxHDL was higher in boys than in girls, but this sex difference was not evident in NW or Ob groups. OxLDL was 23% higher in Ob (p = 0.02), and 56% higher in T2DM (p < 0.01) versus NW and did not differ between boys and girls. MPO was not different between NW and Ob but was 88% (p < 0.02) higher in T2DM compared to NW. Contrary to our hypothesis MPO and insulin resistance (HOMA-IR) were not correlated with oxHDL. OxHDL was positively associated with oxLDL and lean body mass while oxLDL was positively associated with apolipoprotein B, triglycerides, HOMA-IR and trunk fat.
CONCLUSIONS: The higher concentrations of oxHDL and oxLDL, along with higher MPO in children with T2DM reflect higher oxidative stress compared with obesity alone and potentially increased cardiovascular disease risk in youth with T2DM.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Insulin resistance; Obesity; Oxidative stress; Youth

Mesh:

Substances:

Year:  2015        PMID: 25881918      PMCID: PMC9549762          DOI: 10.1016/j.jdiacomp.2015.03.015

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   3.219


  37 in total

Review 1.  Inflammation, atherosclerosis, and coronary artery disease.

Authors:  Göran K Hansson
Journal:  N Engl J Med       Date:  2005-04-21       Impact factor: 91.245

2.  Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size.

Authors:  D L Tribble; L G Holl; P D Wood; R M Krauss
Journal:  Atherosclerosis       Date:  1992-04       Impact factor: 5.162

3.  Elevated plasma myeloperoxidase concentration in adults with obesity.

Authors:  Berndt Zur; Markus Look; Stefan Holdenrieder; Birgit Stoffel-Wagner
Journal:  Clin Chim Acta       Date:  2011-06-15       Impact factor: 3.786

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Predictive value of serum apolipoprotein B/LDL-cholesterol ratio in cardiometabolic risk: population-based cohort study.

Authors:  Altan Onat; Günay Can; Gökhan Ciçek; Erkan Ayhan; Yüksel Doğan
Journal:  Clin Biochem       Date:  2010-09-09       Impact factor: 3.281

6.  High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL.

Authors:  A Golay; L Zech; M Z Shi; Y A Chiou; G M Reaven; Y D Chen
Journal:  J Clin Endocrinol Metab       Date:  1987-09       Impact factor: 5.958

7.  Circulating oxidized LDL and inflammation in extreme pediatric obesity.

Authors:  Anne L Norris; Julia Steinberger; Lyn M Steffen; Andrea M Metzig; Sarah Jane Schwarzenberg; Aaron S Kelly
Journal:  Obesity (Silver Spring)       Date:  2011-02-17       Impact factor: 5.002

8.  Lipoprotein(a) and risk of type 2 diabetes.

Authors:  Samia Mora; Pia R Kamstrup; Nader Rifai; Børge G Nordestgaard; Julie E Buring; Paul M Ridker
Journal:  Clin Chem       Date:  2010-05-28       Impact factor: 8.327

9.  Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients.

Authors:  F R Jornayvaz; M-C Brulhart-Meynet; R W James
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-02-06       Impact factor: 4.222

Review 10.  Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?

Authors:  Roger K Schindhelm; Leonard P van der Zwan; Tom Teerlink; Peter G Scheffer
Journal:  Clin Chem       Date:  2009-06-25       Impact factor: 8.327

View more
  11 in total

1.  Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells.

Authors:  Mohamed I Saad; Taha M Abdelkhalek; Moustafa M Saleh; Maher A Kamel; Mina Youssef; Shady H Tawfik; Helena Dominguez
Journal:  Endocrine       Date:  2015-08-14       Impact factor: 3.633

2.  Effects of a lifestyle intervention on markers of cardiometabolic risk and oxidized lipoproteins among obese adolescents with prediabetes.

Authors:  Ana Rentería-Mexía; Sonia Vega-López; Micah L Olson; Pamela D Swan; Chong D Lee; Allison N Williams; Gabriel Q Shaibi
Journal:  Public Health Nutr       Date:  2018-12-27       Impact factor: 4.022

Review 3.  A review on interplay between obesity, lipoprotein profile and nutrigenetics with selected candidate marker genes of type 2 diabetes mellitus.

Authors:  Mustansir Bhori; Varuni Rastogi; Kanchanlata Tungare; Thankamani Marar
Journal:  Mol Biol Rep       Date:  2021-10-20       Impact factor: 2.316

4.  The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes.

Authors:  Mehryar Zargari; Fahimeh Sharafeddin; Abdolkarim Mahrooz; Ahad Alizadeh; Parisa Masoumi
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-27

5.  Oxidative Stress, DNA Damage and DNA Repair in Female Patients with Diabetes Mellitus Type 2.

Authors:  Annemarie Grindel; Bianca Guggenberger; Lukas Eichberger; Christina Pöppelmeyer; Michaela Gschaider; Anela Tosevska; George Mare; David Briskey; Helmut Brath; Karl-Heinz Wagner
Journal:  PLoS One       Date:  2016-09-06       Impact factor: 3.240

6.  Quantitative Proteomic Analysis of Hepatic Tissue of T2DM Rhesus Macaque.

Authors:  Tingfu Du; Shuaiyao Lu; Qinfang Jiang; Yun Li; Kaili Ma
Journal:  J Diabetes Res       Date:  2017-12-14       Impact factor: 4.011

7.  Oxidized low-density lipoprotein (oxLDL) supports Mycobacterium tuberculosis survival in macrophages by inducing lysosomal dysfunction.

Authors:  Frank Vrieling; Louis Wilson; Patrick C N Rensen; Gerhard Walzl; Tom H M Ottenhoff; Simone A Joosten
Journal:  PLoS Pathog       Date:  2019-04-18       Impact factor: 6.823

Review 8.  Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies.

Authors:  Xiao Jin; Shengjie Yang; Jing Lu; Min Wu
Journal:  Front Cardiovasc Med       Date:  2022-02-10

9.  Regional Fat Distributions Are Associated With Subclinical Right Ventricular Dysfunction in Adults With Uncomplicated Obesity.

Authors:  Jing Liu; Jing Li; Jianqun Yu; Chunchao Xia; Huaxia Pu; Wenzhang He; Xue Li; Xiaoyue Zhou; Nanwei Tong; Liqing Peng
Journal:  Front Cardiovasc Med       Date:  2022-04-25

10.  Oxidative DNA damage and oxidized low density lipoprotein in Type II diabetes mellitus among patients with Helicobacter pylori infection.

Authors:  Wesam Ahmed Nasif; Mohammed Hasan Mukhtar; Mohammed Mahmoud Nour Eldein; Sami Sadagah Ashgar
Journal:  Diabetol Metab Syndr       Date:  2016-05-03       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.